Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02515305 · ClinicalTrials.gov registry record · Phase 3
Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris
A Phase 3 study, sponsored by Padagis.
- Completed
- Registry status
- Phase 3
- Development phase
- 890
- Enrollment target
NCT02515305 is a Phase 3 study that has completed, run by Padagis. The registered enrollment target is 890 participants.
The verdict
NCT02515305, a Phase 3 study, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 890 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment acne vulgaris
Interventions
- DRUG Clindamycin and Benzoyl Peroxide Gel (combination)
- DRUG Clindamycin and Benzoyl Peroxide Gel (Reference) (combination)
- DRUG Placebo gel (combination)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 890 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02515305
The ClinicalTrials.gov registry entry for NCT02515305 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 890 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Padagis, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clindamycin and Benzoyl Peroxide Gel (combination) is the first listed.
NCT02515305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02515305 about?
NCT02515305 is a clinical study titled "Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris". The purpose of this study is to compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment acne vulgaris
What is the current status of trial NCT02515305?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 890 participants. The study started on 2015-07. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02515305?
The interventions under investigation include: Clindamycin and Benzoyl Peroxide Gel (combination) (DRUG), Clindamycin and Benzoyl Peroxide Gel (Reference) (combination) (DRUG), Placebo gel (combination) (DRUG).
Who is sponsoring clinical trial NCT02515305?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.